Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulating Cancer Recurrence Patterns From Post-Treatment Viable Tumor Burden Distributions.

JCO clinical cancer informatics·2026
Same author

The role of diffusion-weighted MRI in biological image-guided radiation therapy: a roadmap.

Physics in medicine and biology·2026
Same author

Cancer-selective photoimmunotherapy spares T cells and NK cells and promotes antitumor immunity in an allogeneic human 3D culture model.

Photochemistry and photobiology·2026
Same author

Gompertz growth with a shared carrying capacity optimally simulates primary and metastatic tumor growth dynamics.

British journal of cancer·2026
Same author

External Validation of the Proliferation Saturation Index Model in Predicting Tumor Volume Regression in Patients With Non-Small Cell Lung Cancer Undergoing Radiation Therapy.

International journal of radiation oncology, biology, physics·2026
Same author

Mathematical modeling of tumor-immune interactions in breast cancer must model tumor-immune interactions in breast cancer.

Journal of theoretical biology·2026

Related Experiment Video

Updated: May 26, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Non-stem cancer cell kinetics modulate solid tumor progression.

Charles I Morton1, Lynn Hlatky, Philip Hahnfeldt

  • 1Center of Cancer Systems Biology, St, Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA. heiko.enderling@tufts.edu

Theoretical Biology & Medical Modelling
|January 3, 2012
PubMed
Summary
This summary is machine-generated.

Cancer stem cells (CSCs) drive tumor growth, but non-stem cancer cell lifespan significantly impacts tumor progression and CSC frequency. Understanding non-stem cell dynamics is key to explaining tumor variability.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

Related Experiment Videos

Last Updated: May 26, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

Area of Science:

  • Oncology
  • Computational Biology
  • Cancer Research

Background:

  • Solid tumors exhibit heterogeneity, with cancer stem cells (CSCs) driving progression.
  • The relative abundance of CSCs varies widely, even within tumors of the same type.
  • Agent-based modeling can explore tumor kinetics with minimal assumptions.

Purpose of the Study:

  • To investigate the role of non-stem cancer cell lifespan in modulating solid tumor progression.
  • To understand how non-stem cell dynamics influence cancer stem cell frequency and tumor growth kinetics.
  • To explore the impact of non-stem cancer cell proliferative capacity on tumor heterogeneity.

Main Methods:

  • Utilized an agent-based cellular automaton model for in silico tumor simulations.
  • Varied the generational life span of non-stem cancer cells as a key parameter.
  • Analyzed tumor growth kinetics and cancer stem cell fraction under different simulation conditions.

Main Results:

  • Tumor growth and CSC expansion are modulated by non-stem cancer cell dynamics.
  • Slight variations in non-stem cell proliferative capacity lead to distinct tumor growth kinetics.
  • Longer non-stem cell lifespans result in self-inhibited tumors; shorter lifespans lead to persistence-limited tumors.

Conclusions:

  • Variability in tumor growth rate and CSC content may stem from non-stem cancer cell proliferation.
  • Intermediate proliferative capacities in non-stem cells yield the fastest-growing tumors.
  • Highlights the crucial role of non-stem cancer cell dynamics in the CSC hypothesis and explains in vivo CSC fraction variations.